What is the main purpose of this 8-K filing?

The main purpose of this 8-K filing is to report Anthem, Inc.'s financial results for the first quarter ended March 31, 2003, via an accompanying press release. It also serves to update investors on the company's operational status and potential future outlook, subject to specific risk factors.

Are the financial results for Q1 2003 detailed in the 8-K itself?

No, the specific financial figures for the first quarter of 2003 are not detailed within the 8-K filing itself. The filing incorporates by reference a press release (Exhibit 99) which contains these financial results and related commentary.

What are some of the key risks mentioned that could affect Anthem's future performance?

The filing mentions several risks, including trends in healthcare costs and utilization, the ability to secure premium rate increases, competitor pricing, increased government regulation of health benefits, significant acquisitions or divestitures by competitors, new prescription drugs and technology, financial strength rating downgrades, increased debt levels, litigation, provider contracting, successful integration of the Trigon Healthcare acquisition, and general economic downturns.

Where can I find more comprehensive financial information and risk disclosures for Anthem?

Investors are urged to carefully review and consider Anthem's other SEC filings, particularly its Annual Report on Form 10-K for the year ended December 31, 2002, which provides more detailed disclosures on the company's financial condition and risks.

ELV 8-K SEC Disclosure — Apr 17, 2003

Summary

Elevance Health, Inc. (formerly Anthem, Inc.) filed a Form 8-K on April 17, 2003, primarily to report its financial results for the first quarter ended March 31, 2003. The filing incorporates a press release containing these results, which are furnished under Regulation FD and do not constitute a formal filing for Section 18 of the Securities Exchange Act of 1934. Investors should note that this report primarily serves as a notification of the release of quarterly financial information and directs them to the accompanying press release for detailed performance metrics. While specific financial figures for the first quarter are not detailed within the 8-K itself, the document emphasizes that the accompanying press release contains forward-looking statements subject to various risks and uncertainties. These include factors such as healthcare cost trends, premium rate adjustments, regulatory changes, competitive landscape, prescription drug utilization, financial ratings, debt levels, litigation, provider contracting, integration of acquisitions (specifically Trigon Healthcare, Inc.), and general economic conditions. Investors are advised to consult Anthem's other SEC filings, such as its Form 10-K for the year ended December 31, 2002, for a comprehensive understanding of the company's financial position and risks.

Key Highlights

1Anthem, Inc. (now Elevance Health) filed an 8-K on April 17, 2003, to report Q1 2003 financial results.
2The financial results were disseminated via a press release filed as Exhibit 99.
3Information is furnished under Regulation FD, not deemed officially 'filed' for Section 18 purposes.
4The report incorporates forward-looking statements regarding future performance.
5Key risks and uncertainties impacting future results are outlined, including healthcare costs, competition, and regulatory factors.
6The company highlights the ongoing integration of the Trigon Healthcare, Inc. acquisition.
7Investors are directed to consult other SEC filings, like the 2002 10-K, for detailed financial information and risk factors.

Elevance Health, Inc. 8-K Report (Apr 17, 2003)

Summary

Key Highlights

Frequently Asked Questions